264 related articles for article (PubMed ID: 8089315)
1. Transsynaptic reduction in N-acetyl-aspartate in cerebellar diaschisis: a proton MR spectroscopic imaging study.
Fulham MJ; Dietz MJ; Duyn JH; Shih HH; Alger JR; Di Chiro G
J Comput Assist Tomogr; 1994; 18(5):697-704. PubMed ID: 8089315
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy (1H MRS) in patients with sporadic cerebellar degeneration.
Terakawa H; Abe K; Watanabe Y; Nakamura M; Fujita N; Hirabuki N; Yanagihara T
J Neuroimaging; 1999 Apr; 9(2):72-7. PubMed ID: 10208103
[TBL] [Abstract][Full Text] [Related]
3. Regional cerebral blood flow and magnetic resonance spectroscopic imaging findings in diaschisis from stroke.
Chu WJ; Mason GF; Pan JW; Hetherington HP; Liu HG; San Pedro EC; Mountz JM
Stroke; 2002 May; 33(5):1243-8. PubMed ID: 11988598
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration.
Tedeschi G; Bertolino A; Massaquoi SG; Campbell G; Patronas NJ; Bonavita S; Barnett AS; Alger JR; Hallett M
Ann Neurol; 1996 Jan; 39(1):71-8. PubMed ID: 8572670
[TBL] [Abstract][Full Text] [Related]
5. Proton MR spectroscopy of cerebellitis.
Guerrini L; Belli G; Cellerini M; Nencini P; Mascalchi M
Magn Reson Imaging; 2002 Oct; 20(8):619-22. PubMed ID: 12467871
[TBL] [Abstract][Full Text] [Related]
6. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Tedeschi G; Lundbom N; Raman R; Bonavita S; Duyn JH; Alger JR; Di Chiro G
J Neurosurg; 1997 Oct; 87(4):516-24. PubMed ID: 9322842
[TBL] [Abstract][Full Text] [Related]
7. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.
Castillo M; Green C; Kwock L; Smith K; Wilson D; Schiro S; Greenwood R
AJNR Am J Neuroradiol; 1995 Jan; 16(1):141-7. PubMed ID: 7900583
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
[TBL] [Abstract][Full Text] [Related]
9. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
10. Investigation of stroke in sickle cell disease by 1H nuclear magnetic resonance spectroscopy.
Wang Z; Bogdan AR; Zimmerman RA; Gusnard DA; Leigh JS; Ohene-Frempong K
Neuroradiology; 1992; 35(1):57-65. PubMed ID: 1289741
[TBL] [Abstract][Full Text] [Related]
11. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
[TBL] [Abstract][Full Text] [Related]
12. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.
Bertolino A; Nawroz S; Mattay VS; Barnett AS; Duyn JH; Moonen CT; Frank JA; Tedeschi G; Weinberger DR
Am J Psychiatry; 1996 Dec; 153(12):1554-63. PubMed ID: 8942451
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy in patients with ischemic stroke.
Federico F; Conte C; Simone IL; Giannini P; Liguori M; Picciola E; Tortorella C; Ferrari E
Ital J Neurol Sci; 1994 Nov; 15(8):413-20. PubMed ID: 7875959
[TBL] [Abstract][Full Text] [Related]
14. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy (1H-MRS) of the cerebellum in men with schizophrenia.
Tibbo P; Hanstock CC; Asghar S; Silverstone P; Allen PS
J Psychiatry Neurosci; 2000 Nov; 25(5):509-12. PubMed ID: 11109301
[TBL] [Abstract][Full Text] [Related]
16. 99Tcm-HMPAO SPET and 1H-MRS (proton magnetic resonance spectroscopy) in patients with ischaemic cerebral infarction.
Lauriero F; Federico F; Rubini G; Conte C; Simone I; Inchingolo V; d'Addabbo A
Nucl Med Commun; 1996 Feb; 17(2):140-6. PubMed ID: 8778638
[TBL] [Abstract][Full Text] [Related]
17. Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias.
Guerrini L; Belli G; Mazzoni L; Foresti S; Ginestroni A; Della Nave R; Diciotti S; Mascalchi M
J Magn Reson Imaging; 2009 Jul; 30(1):11-7. PubMed ID: 19557841
[TBL] [Abstract][Full Text] [Related]
18. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.
Lyoo IK; Kong SW; Sung SM; Hirashima F; Parow A; Hennen J; Cohen BM; Renshaw PF
Psychiatry Res; 2003 Jun; 123(2):87-100. PubMed ID: 12850248
[TBL] [Abstract][Full Text] [Related]
19. Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography.
Go KG; Kamman RL; Mooyaart EL; Heesters MA; Pruim J; Vaalburg W; Paans AM
Neuroradiology; 1995 Apr; 37(3):198-206. PubMed ID: 7603595
[TBL] [Abstract][Full Text] [Related]
20. [Proton magnetic resonance spectroscopy and single photon emission CT in patients with olivopontocerebellar atrophy].
Ikuta N
Rinsho Shinkeigaku; 1998 Apr; 38(4):289-94. PubMed ID: 9742873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
